FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1937-1943

  Koga, S ^a   Hirohata, S ^a   Kondo, Y ^a   Komata, T ^a   Takakura, M ^a   Inoue, M ^a   Kyo, S ^a   Kondo, S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; FADD; Gene therapy; hTERT promoter; Telomerase

Indexed keywords

TELOMERASE;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBUNIT; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CARRIER PROTEINS; DNA-BINDING PROTEINS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FIBROBLASTS; GENE THERAPY; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; LUCIFERASES; MICE; MICE, NUDE; PLASMIDS; PROMOTER REGIONS (GENETICS); TELOMERASE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034904662     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Review: Progress in transcriptionally targeted and regulatable vectors for genetic therapy
2. Cell death and cancer: Replacement of apoptotic genes and inactivation of death suppressor genes in therapy
3. Suppression of human colorectal carcinoma cell growth by wild-type p53
4. In vivo gene therapy with p53 or p21 for prostate cancer
5. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
6. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck
7. Retroviral delivery and tetracycline-dependent expression of IL-1ß-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells
8. Retroviral transfer of CPP32ß gene into malignant gliomas in vitro and in vivo
9. FADD gene therapy for malignant gliomas in vitro and in vivo
10. Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: Overexpression of caspase-7 as a new gene therapy strategy for prostate cancer
11. Tumor chemosensitivity conferred by inserted Herpes simplex thymidine kinase genes: Paradigm for a prospective cancer control strategy
12. Curability of tumors bearing Herpes thymidine kinase genes transferred by retroviral vectors
13. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
14. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
15. Telomeres and telomerase in human cancer
16. Telomerase activity in human cancer
17. Clinical implications of telomerase in cancer
18. The RNA component of human telomerase
19. A mammalian telomerase-associated protein
20. T7.PI: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
21. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
22. Telomerase catalytic subunit homologs from fission yeast and human
23. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTR
24. Telomerase activation by hTR in human normal fibroblasts and hepatocellular carcinomas
25. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
26. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
27. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macro-molecular synthesis
28. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptotecin, and other cytotoxic anti-cancer drugs; a cautionary note
29. Cell death: The significance of apoptosis
30. Apoptosis in the pathogenesis and treatment of disease
31. Implications of apoptotic cell death regulation in cancer therapy
32. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
33. RIP and FADD: Two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways
34. Specific association of human telomerase activity with immortal cells and cancer
35. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis
36. P53, the cellular gatekeeper for growth and division
37. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1ß-converting enzyme
38. Induction of apoptosis in fibroblasts by IL-1ß-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
39. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1ß-converting enzyme
40. Human ICE/CED-3 protease nomenclature
41. A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter
42. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
43. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers
44. Targeting gene therapy to cancer: A review
45. Transcriptional targeting for cancer gene therapy
46. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression
47. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector
48. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC 1 promoter
49. Use of the glucose starvation inducible glucose-regulated protein 78 promoter in suicide gene therapy of murine fibrosarcoma